TLDR:
- Thyme Care, a Nashville-based cancer care enabler, received an investment from Echo Health Ventures and CVS Health Ventures.
- The company plans to use the funds to expand its value-based cancer care model nationally.
The article discusses Thyme Care’s recent strategic investment from Echo Health Ventures and CVS Health Ventures. This investment will allow Thyme Care to accelerate the national expansion of its value-based cancer care model. The company collaborates with health plans, employers, and risk-bearing providers to improve care quality, health outcomes, and reduce the total cost of care. Thyme Care’s approach includes a technology-enabled Care Team and integration with providers to support the entire patient journey.
Cancer care costs are escalating, surpassing other disease areas like heart disease and kidney care. Thyme Care’s provider-centric approach addresses this urgent need for payers to focus on value-driving measures for the cancer population. The investment from Echo Health Ventures and CVS Health Ventures will aid in the national expansion of Thyme Care’s comprehensive cancer care model, offering a path forward for payers and providers seeking to enhance member experience and reduce costs.
The article highlights Thyme Care’s mission to empower oncologists within novel payment models, allowing them to focus on delivering high-quality care while the Care Team manages patient needs between visits. The investment from Echo Health Ventures and CVS Health Ventures recognizes the importance of scalable solutions in the fragmented cancer care experience. Thyme Care’s approach aligns incentives to improve outcomes and lower costs in the value-based cancer care industry.
